Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of botulinum toxin A in knee osteoarthritis
IRCT20151017024572N20Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in knee osteoarthritis (OA), sponsored by Iran University of Medical Sciences. Started Nov 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20151017024572N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151017024572N20.